Loading clinical trials...
Loading clinical trials...
Retrospective, Real-life Observational, Matched Cohort Evaluation of the Effectiveness of BDP/FOR (Fostair® 100/6) and FP/SAL (Seretide® 125) in Patients Switching From Seretide to Fostair in UK Primary Care Asthma Management
Conditions
Interventions
Fixed dose combination salmeterol / fluticasone
Fixed-dose combination beclometasone dipropionate / formoterol
Locations
1
United Kingdom
Optimum Patient Care
Cawston, Norfolk, United Kingdom
Start Date
January 1, 2008
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
June 8, 2012
NCT07219173
NCT02327897
NCT07486401
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Research in Real-Life Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions